In the most recent trading session, Novavax (NVAX) closed at $8.45, indicating a +0.24% shift from the previous trading day.

Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

After two years characterized by layoffs, pipeline reorganizations, FDA delays and clinical holds, Novavax CEO John Jacobs ...

This makes it worthwhile to examine what the stock has in store. Novavax (NVAX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate ...

Novavax shares are trading higher by 13.5% ... currently trading – either way it allows you to profit off of the share price decline. According to data from Benzinga Pro, NVAX has a 52-week ...

Novavax shares fell 11.2% during ... are currently trading – either way it allows you to profit off of the share price decline. According to data from Benzinga Pro, NVAX has a 52-week high ...

We recently compiled a list of the 10 Under-the-Radar Stocks with Massive Upside for 2025. In this article, we are going to ...

This COVID windfall is what launched its stock >$300 per share. The current article ... A quick look at Novavax's 10-year price chart shows the extreme fluctuations its investors have endured ...